Breast cancer: The upgraded role of HER-3 and HER-4
Authors:
- Filitsa A. BadraFBFilitsa A. Badra
- Athanasios G. PapavassiliouAthanasios G. Papavassiliou
- 1 January 2007
- journal article
- review article
- Published by Elsevier in The International Journal of Biochemistry & Cell Biology
- Vol. 39 (5) , 851-856
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Non-palpable breast carcinomas: Correlation of mammographically detected malignant-appearing microcalcifications and epidermal growth factor receptor (EGFR) family expressionCancer Letters, 2006
- EGF–ERBB signalling: towards the systems levelNature Reviews Molecular Cell Biology, 2006
- Meeting Highlights: International Expert Consensus on the Primary Therapy of Early Breast Cancer 2005Annals of Oncology, 2005
- Absence of HER4 Expression Predicts Recurrence of Ductal Carcinoma In situ of the BreastClinical Cancer Research, 2005
- Prognostic and Predictive Factors for Breast Cancer: Translating Technology to OncologyJournal of Clinical Oncology, 2005
- Expression and co-expression of the members of the epidermal growth factor receptor (EGFR) family in invasive breast carcinomaBritish Journal of Cancer, 2004
- Novel therapeutic strategies targeting the epidermal growth factor receptor (EGFR) family and its downstream effectors in breast cancerAnnals of Oncology, 2003
- The deaf and the dumb: the biology of ErbB-2 and ErbB-3Experimental Cell Research, 2003
- EGF receptor ligandsExperimental Cell Research, 2003
- Non‐palpable breast carcinomas: Correlation of mammographically detected malignant‐appearing microcalcifications and molecular prognostic factorsInternational Journal of Cancer, 2002